Navigation Links
Pharmacopeia Announces Management Team Changes
Date:2/28/2008

company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic agreements with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals. For more information please visit the company's website at http://www.pharmacopeia.com.

Contact:

Amy P. Sharpless

Corporate Communications Coordinator

Pharmacopeia, Inc.

(609) 452-3643

This press release, and oral statements made with respect to information contained in this press release, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those which express plan, anticipation, intent, goal, contingency or future development and/or otherwise are not statements of historical fact. These statements are based upon management's current expectations and are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. These forward- looking statements include, but are not limited to, statements about the successful implementation of Pharmacopeia's strategic plans, Pharmacopeia's plans to develop PS433540, a product candidate from its DARA program, Pharmacopeia's Phase 2 and Phase 1 clinical studies with respect to PS433540, including timing and expected outcomes of such studies, Pharmacopeia's plans to develop PS178
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference
2. Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
4. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
5. West Pharmaceutical Services Announces Quarterly Dividend
6. Beijing 2008 Olympic Games Vegetable Supplier Considering Kiwa as a Supplier of Bio-Fertilizers & Kiwa Announces CEO Interview with WallSt.net
7. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
8. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
9. DARA BioSciences, Inc. Announces Appointment of New Director to Board
10. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
11. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Global polyvinyl chloride (PVC) demand registered a significant ... especially in North America and Europe. However, the global ... a growing trend. , The largest chunk of the ... segment. In 2013, the key PVC application spheres included ... film. Moreover, the PVC was consumed in the production ...
(Date:10/30/2014)... San Diego, CA (PRWEB) October 30, 2014 ... company announced today that they have manually curated public ... Pharma and non profit customers. the data is ... BioSciences manually curates and unifies public and internal data ... more value and knowledge out of the data that ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and the ... fleet of high volume High Pressure Processing (HPP) systems. , ... to PackExpo this year, which is where we first announced ... Williams, CEO at Avure. “Sales of the new Avure machine ... the challenges of market demand for higher throughput. We sold ...
(Date:10/30/2014)... 30, 2014  Regado Biosciences, Inc. (Nasdaq: ... conference call and live audio webcast on Thursday, November ... third quarter 2014 financial results. Interested participants ... (888) 347-1165 for domestic callers or (412) 902-4276 for ... under the investor relations section of the Regado website ...
Breaking Biology Technology:Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3Rancho BioSciences Manually Curated TCGA Data Sets Available 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Regado Biosciences to Provide Third Quarter 2014 Financial Results 2
... aOva Technologies , a developer of natural egg protein ... , ,aOva recently announced the closing of its latest financing ... ahead of schedule. The funding, collected from various angel investors, ... of antibody egg products that improve feed efficiency and animal ...
... Madison, Wis. - Wisconsin's two largest cities ... throughout their geographic limits, and several others continue ... addition to localized wireless "hot-spots" offered in public ... Milwaukee, Waukesha, and Shawano continue to make strides ...
... about work life isn't. Everyone knows the present organization ... to translate this into actual practice, despite this having ... , ,This quote by a Dutch man is taken ... Richenda Gambles entitled, "Work-Personal Life Harmonization: Visions and Pragmatic ...
Cached Biology Technology:aOva Technologies raises $3 million 2Wisconsin cities make progress on wireless Internet coverage 2Wisconsin cities make progress on wireless Internet coverage 3Wisconsin cities make progress on wireless Internet coverage 4Work-life imbalance - A global problem getting worse 2Work-life imbalance - A global problem getting worse 3Work-life imbalance - A global problem getting worse 4Work-life imbalance - A global problem getting worse 5
(Date:10/31/2014)... deer still live in Nuristan Province – some 60 ... deer scent glands are more valuable than gold , ... Oryx , NEW YORK (October 31, 2014) ... sighting, a strange deer with vampire-like fangs still persists ... to a research team led by the Wildlife Conservation ...
(Date:10/31/2014)... are letting the air out of a nagging mystery about ... long speculated as to why animal species didn,t flourish sooner, ... prosper at the end of the Proterozoic period, about 800 ... before that, when most researchers think there also was plenty ... great then, after all. , In a study published Oct. ...
(Date:10/31/2014)... in cities is good for attracting species, but it may ... University of Iowa study has found. , The researchers surveyed ... and recorded the abundance of two insects that interact with ... trees, black cherry and black walnut, they didn,t find a ... that feed on the walnuts and black cherries and a ...
Breaking Biology News(10 mins):Strange, fanged deer persists in Afghanistan 2Lack of oxygen delayed the rise of animals on Earth 2Green spaces don't ensure biodiversity in urban areas 2
... animals go through a period of torpor to conserve energy ... to energy-saving mode, the champion by far among vertebrates is ... for several years buried in the mud in the absence ... feat? A team of scientists at the University of Queensland ...
... A group of plant proteins that "shut the door" ... been identified for the first time by a team of ... at UC Berkeley. Findings from the study, which will ... of Science Biology , provide a better understanding of plants, ...
... Netherlands: The efficacy of preimplantation genetic screening (PGS) has ... reproduction over the past few years. None of the ... works or not. Now the European Society of Human,Reproduction ... to try to find out if a novel,method of ...
Cached Biology News:Super-sleepers could help super-sizers! 2Plant protein 'doorkeepers' block invading microbes, study finds 2Plant protein 'doorkeepers' block invading microbes, study finds 3ESHRE launches international study of polar body screening 2
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Biology Products: